YAP1 suppresses the expression of PCK1 by inhibiting the binding of peroxisome proliferator-activated receptor gamma coactivator 1 (PGC1α) to gluconeogenesis gene promoter, which leads to the activation of gluconeogenesis pathway and the progress of HCC. The gene discussed is YAP1; the disease is hepatocellular carcinoma.